Eidogen-Sertanty: Patentable content

Despite the disappointing histories of most bioinformatics companies, Eidogen Inc. and Sertanty Inc. believed they had a sound rationale for merging into a newco, Eidogen-Sertanty Inc., in 2005. The union coupled Sertanty's small molecule-centered IP with classic bioinformatics capabilities from Eidogen, creating a more comprehensive platform. One key difference versus bioinformatics companies in the bubble years is that Eidogen-Sertanty says it can yield solidly patentable compounds.

Eidogen-Sertanty is banking on two revenue streams. It is licensing its structural informatics software for near-term dollars, while it expects its DirectDesign computational discovery collaborations to provide significant royalties down the road...